Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.074 AUD | -2.63% | -5.13% | -48.97% |
04-30 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
04-30 | Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.97% | 103M | |
+7.14% | 217B | |
+13.06% | 194B | |
+20.03% | 143B | |
+30.76% | 111B | |
+3.08% | 64.3B | |
+14.27% | 52.94B | |
+2.06% | 49.53B | |
-5.57% | 38.31B | |
-0.31% | 35.22B |
- Stock Market
- Equities
- IPD Stock
- News ImpediMed Limited
- ImpediMed Partners with GenesisCare for US Launch of Lymphedema Prevention Program